Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted an 88.91% year-on-year (YoY) in net profit after tax in the first half (H1) of fiscal year (FY) 2023/2024, according to financial statements filed to the Egyptian Exchange (EGX) on February 4th.

The company’s net profit after tax jumped to EGP 137.824 million in the six-month period ended December 31st, 2023, from EGP 72.957 million in the year-ago period.

Revenue jumped 27.66% YoY to EGP 999.804 million in the July-December period of 2023, up from EGP 783.166 million in the same period a year earlier.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.

Al Khair River’s profits grow 46.63% YoY in 9 months Updated 12/24/2025 11:07:00 AM

Gadwa’s consolidated profits fall 46.6% YoY in 9 months Updated 11/27/2025 10:24:00 AM

Pioneers properties' consolidated profits drop 76.9% YoY in 9 months Updated 11/27/2025 9:26:00 AM

Panda turns to losses in 9 months Updated 11/23/2025 9:42:00 AM

EFG Holding’s consolidated profits drop 13.44% YoY in 9 months Updated 11/19/2025 1:29:00 PM